Anzahl der Publikationen: 3
Zeitschriftenartikel
Cutsem, Eric van; Tempero, Margaret A.; Sigal, Darren; Oh, Do-Youn; Fazio, Nicola; Macarulla, Teresa; Hitre, Erika; Hammel, Pascal; Hendifar, Andrew E.; Bates, Susan E.; Li, Chung-Pin; Hingorani, Sunil R.; de la Fouchardiere, Christelle; Kasi, Anup; Heinemann, Volker; Maraveyas, Anthony; Bahary, Nathan; Layos, Laura; Sahai, Vaibhav; Zheng, Lei; Lacy, Jill; Park, Joon Oh; Portales, Fabienne; Oberstein, Paul; Wu, Wilson; Chondros, Dimitrios und Bullock, Andrea J.
(2020):
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.
In: Journal of Clinical Oncology, Bd. 38, Nr. 27: S. 3185-3196
Taieb, Julien; Prager, Gerald W.; Melisi, Davide; Westphalen, C. Benedikt; D'Esquermes, Nathalie; Ferreras, Anabel; Carrato, Alfredo und Macarulla, Teresa
(2020):
First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study.
In: Esmo Open, Bd. 5, Nr. 1, e000587
Cutsem, Eric van; Lenz, Heinz-Josef; Furuse, Junji; Tabernero, Josep; Heinemann, Volker; Ioka, Tatsuya; Bazin, Igor; Ueno, Makoto; Csõszi, Tibor; Wasan, Harpreet; Melichar, Bohuslav; Karasek, Petr; Macarulla, Teresa; Ponce, Carmen Guillen; Kalinka-Warzocha, Ewa; Horvath, Zsolt; Prenen, Hans; Schlichting, Michael; Mehdi, Fazal und Bendell, Johanna C.
(2016):
Evofosfamide (TH-302) in combination with gemcitabine in previously untreated patients with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma: Primary analysis of the randomized, double-blind phase III MAESTRO study.
In: Journal of Clinical Oncology, Bd. 34, Nr. 4
Diese Liste wurde am
Sat Nov 16 18:44:02 2024 CET
erstellt.